A multi-omics study of lyophilized fecal microbiota transplantation and bacteria-free sterile fecal filtrate in recurrent ...
“We were able to show that the natural compound argyrin B is highly effective against CDI: both in laboratory experiments and ...
A 2025 survey of NHS employees highlighted worrying variations in awareness of C difficile infection, risk factors and ...
10don MSN
Natural compound shows promise against C difficile while largely sparing healthy gut bacteria
The pathogen Clostridioides difficile (C. difficile) is naturally present in the intestines of many people. When present in ...
An open-label pilot trial found that a single fecal microbiota transplantation cleared adherent-invasive E. coli from the gut ...
Resplice Autism Research Foundation & Institute has opened its second Faecal Microbiota Transplantation (FMT) Centre in India ...
Ajay Goel, PhD, AGAF, explains the significance of 2 new studies that found that early-onset colorectal cancer (EOCRC) and recurrence in CRC could both be predicted using new blood and tissue tests.
New clinical data show omilancor reduced a molecular signature associated with biologic refractoriness by more than 55% in ulcerative colitis and Crohn’s disease patients. Omila ...
Monthly long-form interviews will air on Bloomberg Television across four regions and on TV's YouTube channel, which has more ...
Three widely used drug classes have quietly lost ground in the evidence, yet many Americans over 65 are still on them today.
Detailed price information for Redhill Biophrma ADR (RDHL-Q) from The Globe and Mail including charting and trades.
Executing a full strategic portfolio reset, RedHill is now a stronger commercial entity with Rebyota® and Clenpiq®, two established FDA-approved gastrointestinal (GI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results